The Human Microbiome Market size (volume and value) and Market chain structure published by the insight partners through its high-quality database which is a valuable source of guidance and direction for companies and individual interested in the Market. Major companies with their market volumes and revenues are covered for each of the regions (north america, europe, asia pacific, middle east & africa, south & central america).
Request sample pages of this research study at – https://www.theinsightpartners.com/sample/TIPBT00002233/
The human microbiome market is expected to reach US$ 2,921.68 million by 2028 from US$ 718.95 million in 2021; it is estimated to grow at a CAGR of 22.2% during 2021–2028.
The human microbiota consists of the trillions of symbiotic microbial cells harbored by each person mainly bacteria in the gut. The microbes, including bacteria, fungi, and viruses, are the disease-causing agent that accumulate over time, and the habitat in gut transforms their genetic activities and metabolic processes, resulting in an abnormal immune response against the substances and tissues that normally present in the human body. Several microbiome projects have been launched worldwide with the aim to understand the roles played by these symbionts and their impact on the health of human host. The growth of the human microbiome market is attributed to the factors such as increasing incidence of lifestyle diseases, increasing focus on human microbiome therapies, and growing technological advancements in metagenomics and next-generation sequencing. However strict government guidelines and lack of knowledge about detailed examination hinders the market growth.
Order a copy of this research study at –
Based on product, the human microbiome market is segmented into foods, medical foods, probiotics, prebiotics, drugs, diagnostic devices, and supplements. The probiotics segment is projected to hold the largest market share in 2021, and the prebiotics segment is anticipated to register the highest CAGR in the market during the forecast period.
The human microbiome market, by disease, is segmented into diabetes, cancer, autoimmune disorders, obesity, mental disorders, and other diseases. The market for the human microbiome is emerging owing to rising incidences of lifestyle diseases such as cancer and diabetes. The obesity segment is expected to hold the largest share of the market in 2021, whereas the diabetes segment is estimated to register the highest CAGR during the forecast period.
The human microbiome market, by application, is segmented into diagnostics and therapeutics. The therapeutics segment is projected to hold a larger market share in 2021, and it is further estimated to register a higher CAGR during the forecast period
The prominent/emerging players in the Human Microbiome Market research include:
- Rebiotix Inc.
- Yakult Honsha Co., Ltd.
- Synthetic Biologics Inc.
- MaaT Pharma
- Eligo Bioscience
- Merck & Co. Inc
- AOBiome LLC
- Seres Therapeutics
Company overview provides the information about location of the company where it is headquartered along with the established year, employee strength as of 2017, regions where the company is operating and the key business areas.
Overall company/segment revenue for the year 2019, 2018, and 2017 is provided in the sub title “financial performance” (public listed companies) along with the analysis and explanation of the increase or decrease in the same due to factors such as mergers & acquisition, profit or loss in any strategic business unit (sbus) and others.
Product benchmarking comprises the comprehensive list of products pertaining to the respective market along with the application and key features.
Insights pertaining to the new product launch, strategic collaboration, mergers and acquisition, regulatory approval, and other developments by the company in market are covered under strategic initiatives section.
The insight partners is a one stop Market research provider of actionable solutions. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.
Our research model is very simple. We believe in client servicing and delivering best quality to our customers. Through our research content, we are making sure that our customers get value of their money along with better quality data and analysis.
Our research content is majorly focused towards market trends in terms of market sizing, competitive landscaping, company analysis, regional or country analysis etc. We provide detailed break-up of segmentation in terms of geography, technology, product and services etc.; which helps our clients to get a deeper analysis on various research topics.
If you have any queries about this report or would like further information, please contact us:
North america: +1 646 491 9876
Asia-pacific: +91 20 6727 8686
Email: [email protected]